Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Interference with RhoA-ROCK Signaling Mechanism in Autoreactive CD4(+) T Cells Enhances the Bioavailability of 1,25-Dihydroxyvitamin D(3) in Experimental Autoimmune Encephalomyelitis.
Galectin-1 for neuroprotection?
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
Administration of monthly-pulse cyclophosphamide in multiple sclerosis patients. Effects of long-term treatment on immunologic parameters.
Pilates based core stability training in ambulant individuals with multiple sclerosis: Protocol for a multi-centre randomised controlled trial.
The International Symposium on the Multiple Sclerosis Brain
Helminth therapy and multiple sclerosis.
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group.
Development of the Brief Inventory of Perceived Stress.
A comparative study of experimental mouse models of central nervous system demyelination.
Multiple sclerosis susceptibility genes: associations with relapse severity and recovery.
Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort study.
Acute Cryptococcal Immune Reconstitution Inflammatory Syndrome in a Patient on Natalizumab.
Effect of Genzyme’s LEMTRADA™ maintained in patients beyond two-year pivotal MS studies
Time limited immunomodulatory functions of transplanted neural precursor cells.
Patients with migraine do not have MRI-visible cortical lesions.
Clinical overview of the seizure risk of dalfampridine.
Tumefactive multiple sclerosis lesions under fingolimod treatment.
First use of alemtuzumab in Balo's concentric sclerosis: a case report.
Modeling probability of additional cases of natalizumab-associated JCV sero-negative progressive multifocal leukoencephalopathy.
Neuroimmune Crosstalk in CNS Disorders: The Histamine Connection.
Rehabilitation interventions in multiple sclerosis: an overview.
Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis.
The effect of Nintendo(R) Wii(R) on balance in people with multiple sclerosis: a pilot randomized control study.
Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
Pages
« first
‹ previous
…
139
140
141
142
143
144
145
146
147
…
next ›
last »